Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Alves-Filho, Jose C."" wg kryterium: Autor


Tytuł :
The PI3Kγ/AKT signaling pathway mediates peripheral antinociceptive action of dipyrone.
Autorzy :
Cecílio NT; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology Ribeirão Preto Medical School, University of Sao Paulo, Av. Bandeirantes, Ribeirão Preto, SP, 3900, 14049-900, Brazil.
Souza GR; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology Ribeirão Preto Medical School, University of Sao Paulo, Av. Bandeirantes, Ribeirão Preto, SP, 3900, 14049-900, Brazil.
Alves-Filho JC; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology Ribeirão Preto Medical School, University of Sao Paulo, Av. Bandeirantes, Ribeirão Preto, SP, 3900, 14049-900, Brazil.
Cunha FQ; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology Ribeirão Preto Medical School, University of Sao Paulo, Av. Bandeirantes, Ribeirão Preto, SP, 3900, 14049-900, Brazil.
Cunha TM; Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology Ribeirão Preto Medical School, University of Sao Paulo, Av. Bandeirantes, Ribeirão Preto, SP, 3900, 14049-900, Brazil.
Pokaż więcej
Źródło :
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2021 Apr; Vol. 35 (2), pp. 364-370. Date of Electronic Publication: 2020 Oct 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
Autorzy :
Rodrigues TS; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
de Sá KSG; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Ishimoto AY; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Becerra A; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Oliveira S; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Almeida L; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.; Center of Research in Inflammatory Diseases, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Gonçalves AV; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Perucello DB; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Andrade WA; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Castro R; Departamento de Análises Clínicas, Toxicológicas e Bromatologia, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Veras FP; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Toller-Kawahisa JE; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Nascimento DC; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
de Lima MHF; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Silva CMS; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Caetite DB; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Martins RB; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Castro IA; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Pontelli MC; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
de Barros FC; Departamento de Biologia, Faculdade de Filosofia Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.; Departamento de Ecologia e Biologia Evolutiva, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, Brazil.
do Amaral NB; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Giannini MC; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Bonjorno LP; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Lopes MIF; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Santana RC; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Vilar FC; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Auxiliadora-Martins M; Divisão de Medicina Intensiva, Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Luppino-Assad R; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
de Almeida SCL; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
de Oliveira FR; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Batah SS; Departamento de Patologia e Medicina Legal, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Siyuan L; Departamento de Patologia e Medicina Legal, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Benatti MN; Departamento de Patologia e Medicina Legal, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Cunha TM; Center of Research in Inflammatory Diseases, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Alves-Filho JC; Center of Research in Inflammatory Diseases, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Cunha FQ; Center of Research in Inflammatory Diseases, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.; Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Cunha LD; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Frantz FG; Departamento de Análises Clínicas, Toxicológicas e Bromatologia, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Kohlsdorf T; Departamento de Biologia, Faculdade de Filosofia Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Fabro AT; Departamento de Patologia e Medicina Legal, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Arruda E; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
de Oliveira RDR; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Louzada-Junior P; Divisão de Imunologia Clinica, Emergência, Doenças Infecciosas e Unidade de Terapia Intensiva, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Zamboni DS; Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.; Center of Research in Inflammatory Diseases, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Pokaż więcej
Źródło :
The Journal of experimental medicine [J Exp Med] 2021 Mar 01; Vol. 218 (3).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Severity of Illness Index*
COVID-19/*pathology
COVID-19/*virology
Inflammasomes/*metabolism
SARS-CoV-2/*physiology
Apoptosis ; Comorbidity ; Cytokines/biosynthesis ; Humans ; Lung/pathology ; Monocytes/metabolism ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Postmortem Changes ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
Autorzy :
Lopes MI; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Bonjorno LP; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Giannini MC; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Amaral NB; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Menezes PI; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Dib SM; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Gigante SL; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Benatti MN; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Rezek UC; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Emrich-Filho LL; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Sousa BAA; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Almeida SCL; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Luppino Assad R; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Veras FP; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Schneider A; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Rodrigues TS; Department of Cell Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Leiria LOS; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Cunha LD; Department of Cell Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Alves-Filho JC; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Cunha TM; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Arruda E; Department of Cell Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Miranda CH; Department of Emergency Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Pazin-Filho A; Department of Emergency Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Auxiliadora-Martins M; Department of Surgery and Anatomy, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Borges MC; Department of Emergency Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Fonseca BAL; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Bollela VR; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Del-Ben CM; Department of Neuroscience and Behaviour, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Cunha FQ; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Zamboni DS; Department of Cell Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Santana RC; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Vilar FC; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Louzada-Junior P; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
Oliveira RDR; Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil .
Pokaż więcej
Źródło :
RMD open [RMD Open] 2021 Feb; Vol. 7 (1).
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Length of Stay*
Oxygen Inhalation Therapy*
Severity of Illness Index*
COVID-19/*drug therapy
Colchicine/*administration & dosage
SARS-CoV-2/*genetics
Adult ; Aged ; COVID-19/mortality ; COVID-19/virology ; Colchicine/adverse effects ; Diarrhea/chemically induced ; Double-Blind Method ; Female ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Reverse Transcriptase Polymerase Chain Reaction ; Time Factors ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis.
Autorzy :
Fattori V; Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Brazil.
Staurengo-Ferrari L; Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Brazil.
Zaninelli TH; Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Brazil.
Casagrande R; Department of Pharmaceutical Science, Londrina State University, Londrina, Brazil.
Oliveira RD; Division of Clinical Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Louzada-Junior P; Division of Clinical Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Cunha TM; Department of Pharmacology, Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Alves-Filho JC; Department of Pharmacology, Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Teixeira MM; Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Cunha FQ; Department of Pharmacology, Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Amaral FA; Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Verri WA Jr; Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Brazil. .; Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, PR 445, KM 380, PO Box 10.011, Londrina, Parana, 86057-970, Brazil. .
Pokaż więcej
Źródło :
Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2020 Dec; Vol. 69 (12), pp. 1271-1282. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article
MeSH Terms :
Arthritis, Gouty/*pathology
Inflammation/*chemically induced
Interleukin-1beta/*metabolism
Interleukin-33/*pharmacology
Macrophages/*metabolism
Pain/*chemically induced
Animals ; Arthritis, Gouty/chemically induced ; Arthritis, Gouty/metabolism ; Female ; Humans ; Inflammation/psychology ; Interleukin-1 Receptor-Like 1 Protein/genetics ; Macrophages/drug effects ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Middle Aged ; Neutrophil Infiltration/drug effects ; Pain/psychology ; Peroxidase/metabolism ; Superoxides/metabolism ; Synovial Membrane/pathology ; Uric Acid
Czasopismo naukowe
Tytuł :
IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis
Autorzy :
Fattori, Victor
Staurengo-Ferrari, Larissa
Zaninelli, Tiago H.
Casagrande, Rubia
Oliveira, Rene D.
Louzada-Junior, Paulo
Cunha, Thiago M.
Alves-Filho, Jose C.
Teixeira, Mauro M.
Cunha, Fernando Q.
Amaral, Flavio A.
Verri, Jr, Waldiceu A.Aff1, Aff6
Pokaż więcej
Źródło :
Inflammation Research: Official Journal of:The International Association of Inflammation Societies +The European Histamine Research Society. 69(12):1271-1282
Czasopismo naukowe
Tytuł :
MEK5/ERK5 signaling mediates IL-4-induced M2 macrophage differentiation through regulation of c-Myc expression.
Autorzy :
Luiz JPM; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Toller-Kawahisa JE; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Viacava PR; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Nascimento DC; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Pereira PT; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Saraiva AL; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Prado DS; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
LeBert M; CNRS, UMR7355, Orléans, France.; Experimental and Molecular Immunology and Neurogenetics, University of Orléans, Orléans, France.
Giurisato E; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Tournier C; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Cunha TM; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Cunha FQ; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Quesniaux V; CNRS, UMR7355, Orléans, France.; Experimental and Molecular Immunology and Neurogenetics, University of Orléans, Orléans, France.
Ryffel B; CNRS, UMR7355, Orléans, France.; Experimental and Molecular Immunology and Neurogenetics, University of Orléans, Orléans, France.
Alves-Filho JC; Center for Research in Inflammatory Diseases and Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Pokaż więcej
Źródło :
Journal of leukocyte biology [J Leukoc Biol] 2020 Oct; Vol. 108 (4), pp. 1215-1223. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Differentiation/*immunology
Interleukin-4/*immunology
MAP Kinase Kinase 5/*immunology
MAP Kinase Signaling System/*immunology
Macrophages/*immunology
Mitogen-Activated Protein Kinase 7/*immunology
Proto-Oncogene Proteins c-myc/*immunology
Animals ; Antigens, Differentiation/genetics ; Antigens, Differentiation/immunology ; Cell Differentiation/genetics ; Gene Expression Regulation/immunology ; Interleukin-4/genetics ; MAP Kinase Kinase 5/genetics ; MAP Kinase Signaling System/genetics ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Mitogen-Activated Protein Kinase 7/genetics ; Proto-Oncogene Proteins c-myc/genetics ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/immunology ; STAT6 Transcription Factor/genetics ; STAT6 Transcription Factor/immunology
Czasopismo naukowe
Tytuł :
Molecular basis of carrageenan-induced cytokines production in macrophages.
Autorzy :
Lopes AH; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Silva RL; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Fonseca MD; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Gomes FI; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Maganin AG; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Ribeiro LS; Institute of Innate Immunity, University Hospitals, University of Bonn, 53127, Bonn, Germany.
Marques LMM; Department of Physics and Chemistry, University of São Paulo, Ribeirão Preto, SP, Brazil.
Cunha FQ; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Alves-Filho JC; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Zamboni DS; Department of Cellular and Molecular Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Lopes NP; Department of Physics and Chemistry, University of São Paulo, Ribeirão Preto, SP, Brazil.
Franklin BS; Institute of Innate Immunity, University Hospitals, University of Bonn, 53127, Bonn, Germany.
Gombault A; University of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Ramalho FS; Department of Pathology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Quesniaux VFJ; University of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Couillin I; University of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Ryffel B; University of Orleans and CNRS, UMR7355 Experimental and Molecular Immunology, Orleans, France.
Cunha TM; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Center for Research in Inflammatory Diseases (CRID)Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil. .
Pokaż więcej
Źródło :
Cell communication and signaling : CCS [Cell Commun Signal] 2020 Sep 07; Vol. 18 (1), pp. 141. Date of Electronic Publication: 2020 Sep 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Macrophage Activation*
Carrageenan/*immunology
Cytokines/*immunology
Macrophages, Peritoneal/*immunology
Animals ; Cells, Cultured ; Inflammasomes/immunology ; Inflammation/immunology ; Interleukin-1beta/immunology ; Male ; Mice ; Mice, Inbred C57BL ; NLR Family, Pyrin Domain-Containing 3 Protein/immunology ; Tumor Necrosis Factor-alpha/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies